Internet Promotion Warning Letters Continue In Guidance Vacuum
This article was originally published in The Gray Sheet
Executive Summary
Counsel for OmniCorder Technologies is preparing a response to an April 18 warning letter citing Internet promotions representing the firm's BioScan system "as a stand-alone diagnostic device for breast cancer detection," the company says.